Human Topoisomerase I Inhibition: Docking Camptothecin and Derivatives into a Structure-Based Active Site Model-Reference-Cited by-同舟云学术

Human Topoisomerase I Inhibition: Docking Camptothecin and Derivatives into a Structure-Based Active Site Model

Published:2002-01-11 Issue:5 Volume:41 Page:1428-1435
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Laco Gary S.¹,Collins Jack R.¹,Luke Brian T.¹,Kroth Heiko¹,Sayer Jane M.¹,Jerina Donald M.¹,Pommier Yves¹

Affiliation:

1. Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, and Advanced Biomedical Computing Center, National Cancer Institute−Frederick/SAIC, Frederick, Maryland 21702

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi011774a

Reference70 articles.

1. Optimum chemotherapy for ovarian cancer

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review and Current Perspectives on DNA Topoisomerase I and II Enzymes of Fungi as Study Models for the Development of New Antifungal Drugs;Journal of Fungi;2024-09-03

2. The recent developments of camptothecin and its derivatives as potential anti-tumor agents;European Journal of Medicinal Chemistry;2023-11

3. Mechanism of action of non-camptothecin inhibitor Genz-644282 in topoisomerase I inhibition;Communications Biology;2022-09-16

4. Molecular modeling, DFT quantum chemical analysis, and molecular docking on edotecarin, an indolocarbazole anticancer agent;Molecular Crystals and Liquid Crystals;2022-06-06

5. Design, Synthesis, and Bioevaluation of Novel Enzyme-Triggerable Cell Penetrating Peptide-Based Dendrimers for Targeted Delivery of Camptothecin and Cancer Therapy;Journal of Medicinal Chemistry;2022-04-05